Continuum Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Continuum Advisory's CL Position: Q2 2026 in Review
Continuum Advisory opened a new position in Colgate-Palmolive (CL) in Q2 2026: 888 shares worth $81.4K. The stake represents 0.01% of the portfolio and ranks #682 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in CL as recently as Q1 2025.
Continuum Advisory first reported a position in CL in Q1 2024 and has held it in 6 quarters since. The position peaked at $110K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Continuum Advisory held 888 shares of Colgate-Palmolive worth $81.4K as of Q2 2026.
- Colgate-Palmolive was a new Continuum Advisory position in Q2 2026.
- Colgate-Palmolive made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #682 holding.
- Continuum Advisory first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 6 quarters since.
- Continuum Advisory's Colgate-Palmolive position peaked at $110K in Q1 2025.
- 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.